Risk of a decline in share prices and delays in raising funds due to COVID-19
First written in FY2020. 1 of 2 entries say "Restated". Latest entry: FY2021.
The whole theme swung hardest in 2023: 1 of 10 companies on the "Worse" side.
2 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「If the prolonged stagnation of our share price, including a situation in which it remains below the minimum exercise price of the stock acquisition rights with an exercise-price adjustment clause, continues, exercise of the stock acquisition rights we issue may not proceed as assumed. This could delay the planned fundraising or prevent us from raising the amount originally scheduled.」
The company continues to disclose the risk that a depressed share price could lead to delayed exercise of stock acquisition rights and a shortfall in funds raised. - FY2020First statedAnnual report
「If the prolonged stagnation of our share price, including a situation in which it remains below the minimum exercise price of the stock acquisition rights with an exercise-price adjustment clause, continues, exercise of the stock acquisition rights we issue may not proceed as assumed. This could delay the planned fundraising or prevent us from raising the amount originally scheduled.」
The company first disclosed the risk that the impact of COVID-19 on the stock market could affect its fundraising and business plans through delays in exercising stock acquisition rights and a shortfall in funds raised.